Selective high-dose intra-arterial cisplatin as palliative treatment for incurable head and neck cancer

Onkologie

Volumn 27, Issue 6, 2004, Pages 547-551

  Teymoortash, A ^a,b   Bien, S ^b   Dalchow, C ^a   Sesterhenn, A ^a   Lippert, B M ^a   Werner, J A ^a  

^a Dept Otolaryngol Hd Neck Surg ^*  (Germany)

^b PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Cisplatin; Head and neck cancer, advanced; Intra arterial chemotherapy, selective; Palliative therapy

Indexed keywords

CISPLATIN; SODIUM THIOSULFATE;

ADULT; ARTICLE; BLEEDING; CANCER PAIN; CANCER PALLIATIVE THERAPY; CARDIOTOXICITY; CHEMOTHERAPY INDUCED EMESIS; CLINICAL ARTICLE; CLINICAL TRIAL; DIARRHEA; DRUG MEGADOSE; DRUG TOLERABILITY; FEMORAL ARTERY; HEAD AND NECK CARCINOMA; HUMAN; MALE; NEPHROTOXICITY; NEUROTOXICITY; OTOTOXICITY; PAIN; RESPIRATORY FAILURE; SQUAMOUS CELL CARCINOMA; TUMOR GROWTH; VOMITING;

ANTINEOPLASTIC AGENTS; CISPLATIN; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; GERMANY; HEAD AND NECK NEOPLASMS; HUMANS; INFUSIONS, INTRA-ARTERIAL; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASMS, SQUAMOUS CELL; PALLIATIVE CARE; TREATMENT FAILURE; TREATMENT OUTCOME;

EID: 10844294085     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000081336     Document Type: Article

References (29)

1. Dennington ML, Carter DR, Meyers AD: Distant metastases in head and neck epidermoid carcinoma. Laryngoscope 1980;90:196-201.
2. Vokes EE, Weichselbaum RR, Lippman SM, Hong WK: Head and neck cancer. N Engl J Med 1993;328:184-194.
3. Hart AA, Mak-Kregar S, Hilgers FJ, Levendag PC, Manni JJ, Spoelstra HA, Bruaset IA, van der Laan BF, Annyas AA, van der Beek JM: The importance of correct stage grouping in oncology. Results of a nationwide study of oropharyngeal carcinoma in The Netherlands. Cancer 1995;75:2656-2662.
4. Haddad R, Tishler RB, Norris CM, Mahadevan A, Busse P, Wirth L, Goguen LA, Sullivan CA, Costello R, Case MA, Posner MR: Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-modality treatment. Oncologist 2003;8:35-44.
5. Brizel DM, Albers ME, Fisher SR, Scher RL, Richtsmeier WJ, Hars V, George SL, Huang AT, Prosnitz LR: Hyperfractionated irradiation with or without concurrent chemotherapy for locally advanced head and neck cancer. N Engl J Med 1998; 338:1798-1804.
6. Wendt TG, Grabenbauer GG, Rodel CM, Thiel HJ, Aydin H, Rohloff R, Wustrow TP, Iro H, Popella C, Schalhorn A: Simultaneous radiochemotherapy versus radiotherapy alone in advanced head and neck cancer: A randomized multicenter study. J Clin Oncol 1998;16:1318-1324.
7. Pignon JP, Bourhis J, Domenge C, Designe L: Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: Three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer. Lancet 2000;355:949-955.
8. Aisner J, Jacobs M, Sinabaldi V, Gray W, Eisenberger M: Chemoradiotherapy for the treatment of regionally advanced head and neck cancers. Semin Oncol 1994;21:35-44.
9. Teymoortash A, Werner JA: Selective intraarterial cisplatin chemotherapy in treatment of advanced malignant lesions of the head and neck. Cancer Ther 2003;1:269-273.
10. Robbins KT, Kumar P, Regine WF, Wong FS, Weir AB 3rd, Flick P, Kun LE, Palmer R, Murry T, Fontanesi J, Ferguson R, Thomas R, Hartsell W, Paig CU, Salazar G, Norfleet L, Hanchett CB, Harrington V, Niell HB: Efficacy of targeted supradose cisplatin and concomitant radiation therapy for advanced head and neck cancer: The Memphis experience. Int J Radiat Oncol Biol Phys 1997;38:263-271.
11. Gemmete JJ: Complications associated with selective high-dose intraarterial cisplatin and concomitant radiation therapy for advanced head and neck cancer. J Vasc Interv Radiol 2003;14:743-748.
12. Naidu SI, Samant S, Vieira F: Selective versus nonselective intraarterial chemoradiation for tonsil cancer. Otolaryngol Head Neck Surg 2003;129:122-123.
13. Robbins KT, Storniolo AM, Hryniuk WM, Howell SB: 'Decadose' effects of cisplatin on squamous cell carcinoma of the upper aerodigestive tract. II. Clinical studies. Laryngoscope 1996;106:37-42.
14. Werner JA, Kehrl W, Pluzanska A, Arndt O, Lavery KM, Glaholm J, Dietz A, Dyckhoff G, Maune S, Stewart ME, Orenberg EK, Leavitt RD: A phase III placebo-controlled study in advanced head and neck cancer using intratumoural cisplatin/epinephrine gel. Br J Cancer 2002;21:938-944.
15. Milas L, Mason KA, Liao Z, Ang KK: Chemoradiotherapy: Emerging treatment improvement strategies. Head Neck 2003;25:152-167.
16. Inoue K, Mukaiyama T, Mitsui I, Ogawa M: In vitro evaluation of anticancer drugs in relation to development of drug resistance in the human tumor clonogenic assay. Cancer Chemother Pharmacol 1985;15:208-211.
17. Andrews PA, Jones JA, Varki NM, Howell SB: Rapid emergence of acquired cis-diamminedichloroplatinum( II) resistance in an in vivo model of human ovarian carcinoma. Cancer Commun 1990;2:93-100.
18. Klopp CT, Alfort TC, Bateman J: Fractionated intaarterial cancer chemotherapy with methyl bis amine hydrochloride: A preliminary report. Ann Surg 1950;132:811-832.
19. von Hoff DD, Clark GM, Weiss GR, Marshall MH, Buchok JB, Knight WA 3d, LeMaistre C: Use of in vitro dose response effects to select antineoplastics for high-dose or regional administration regimens. Clin Oncol 1986;4:1827-1834.
20. Teicher BA, Holden SA, Kelley MJ, Shea TC, Cucchi CA, Rosowsky A, Henner WD, Frei E 3d.: Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum( II). Cancer Res 1987;47:388-393.
21. Howell SB, Taetle R: Effect of sodium thiosulfate on cis- dichlorodiammineplatinum(II) toxicity and antitumor activity in L1210 leukemia. Cancer Treat Rep 1980;64:611-616.
22. Campbell TN, Howell SB, Pfeifle CE, Wung WE, Bookstein J: Clinical pharmacokinetics of intraarterial cisplatin in humans. J Clin Oncol 1983;1:755-762.
23. Kreidler JF, Petzel JR: Combined treatment of maxillofacial carcinoma by intraarterial proliferation block and irradiation. Recent Results Cancer Res 1983;86:152-161.
24. Kerber CW, Wong WH, Howell SB, Hanchett K, Robbins KT: An organ-preserving selective arterial chemotherapy strategy for head and neck cancer. Am J Neuroradiol 1998;19:935-941.
25. Robbins KT, Wong FS, Kumar P, Hartsell WF, Vieira F, Mullins B, Niell HB: Efficacy of targeted chemoradiation and planned selective neck dissection to control bulky nodal disease in advanced head and neck cancer. Arch Otolaryngol Head Neck Surg 1999;125:670-675.
26. Benazzo M, Caracciolo G, Zappoli F, Bernardo G, Mira E: Induction chemotherapy by superselective intraarterial high-dose carboplatin infusion for head and neck cancer. Eur Arch Otorhinolaryngol 2000;257:279-282.
27. Samant S, Robbins KT, Kumar P, Ma JZ, Vieira F, Hanchett C: Bone or cartilage invasion by advanced head and neck cancer: Intraarterial supradose cisplatin chemotherapy and concomitant radiotherapy for organ preservation. Arch Otolaryngol Head Neck Surg 2001;127:1451-1456.
28. Furutani K, Fuwa N, Kodaira T, Matsumoto A, Kamata M, Tachibana H, Sakahara H: Continuous selective intra-arterial chemotherapy in combination with irradiation for locally advanced cancer of the tongue and tongue base. Oral Oncol 2002;38:145-152.
29. Stephens FO, Harker GJ, Crea P: The intraarterial infusion of chemotherapeutic agents as 'basal' treatment of cancer: Evidence of increased drug activity in regionally infused tissues. Aust N Z J Surg 1980;50:597-602.